Introduction : the challenge of multiresistanceLIVERMORE, David M.International journal of antimicrobial agents. 2007, Vol 29, issn 0924-8579, S1-S7, SUP3Article

Fourteen years in resistanceLIVERMORE, David M.International journal of antimicrobial agents (Print). 2012, Vol 39, Num 4, pp 283-294, issn 0924-8579, 12 p.Article

Tigecycline : what is it, and where should it be used?LIVERMORE, David M.Journal of antimicrobial chemotherapy (Print). 2005, Vol 56, Num 4, pp 611-614, issn 0305-7453, 4 p.Article

Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare?LIVERMORE, David M.Clinical infectious diseases. 2002, Vol 34, Num 5, pp 634-640, issn 1058-4838Article

Doripenem : antimicrobial profile and clinical potentialLIVERMORE, David M.Diagnostic microbiology and infectious disease. 2009, Vol 63, Num 4, pp 455-458, issn 0732-8893, 4 p.Article

The threat from the pink cornerLIVERMORE, David M.Annals of medicine (Helsinki). 2003, Vol 35, Num 4, pp 226-234, issn 0785-3890, 9 p.Article

Discovery research: the scientific challenge of finding new antibioticsLIVERMORE, David M.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 9, pp 1941-1944, issn 0305-7453, 4 p.Article

Problem pathogensLIVERMORE, David M.International journal of antimicrobial agents. 2007, Vol 29, issn 0924-8579, 53 p., SUP3Serial Issue

Minimising antibiotic resistanceLIVERMORE, David M.Lancet. Infectious diseases (print). 2005, Vol 5, Num 7, pp 450-459, issn 1473-3099, 10 p.Article

Of Pseudomonas, porins, pumps and carbapenemsLIVERMORE, David M.Journal of antimicrobial chemotherapy (Print). 2001, Vol 47, Num 3, pp 247-250, issn 0305-7453Article

EnterobacteriaceaeDENTON, Miles.International journal of antimicrobial agents. 2007, Vol 29, issn 0924-8579, S9-S22, SUP3Article

Carbapenemases : a problem in waiting ? : AntimicrobialsLIVERMORE, David M; WOODFORD, Neil.Current opinion in microbiology. 2000, Vol 3, Num 5, pp 489-495, issn 1369-5274Article

Antibiotic resistance in staphylococciLIVERMORE, David M.International journal of antimicrobial agents. 2000, Vol 16, pp S3-S10, issn 0924-8579, SUP1Article

Doripenem versus Pseudomonas aeruginosa in vitro: Activity against characterized isolates, mutants, and transconjugants and resistance selection potentialMUSHTAQ, Shazad; YIGONG GE; LIVERMORE, David M et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 8, pp 3086-3092, issn 0066-4804, 7 p.Article

Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumanniiAFZAL-SHAH, Mariya; WOODFORD, Neil; LIVERMORE, David M et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 2, pp 583-588, issn 0066-4804Article

Carbapenem antibiotics for serious infectionsHAWKEY, Peter M; LIVERMORE, David M.BMJ (Overseas and retired doctors ed.). 2012, Vol 344, Num 7863, pp 43-47, issn 1759-2151, 5 p.Article

Activity of the anti-MRSA carbapenem razupenem (PTZ601) against Enterobacteriaceae with defined resistance mechanismsLIVERMORE, David M; MUSHTAQ, Shazad; WARNER, Marina et al.Journal of antimicrobial chemotherapy (Print). 2009, Vol 64, Num 2, pp 330-335, issn 0305-7453, 6 p.Article

Bacterial resistance: Origins, epidemiology, and impactLIVERMORE, David M.Clinical infectious diseases. 2003, Vol 36, pp S11-S23, issn 1058-4838, SUP1Article

Has the era of untreatable infections arrived?LIVERMORE, David M.Journal of antimicrobial chemotherapy (Print). 2009, Vol 64, issn 0305-7453, i29-i36, SUP1Conference Paper

In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocciJOHNSON, Alan P; WARNER, Marina; LIVERMORE, David M et al.Journal of antimicrobial chemotherapy (Print). 2002, Vol 50, Num 1, pp 89-93, issn 0305-7453Article

Chequerboard titration of cephalosporin CXA-101 (FR264205) and tazobactam versus β-lactamase-producing EnterobacteriaceaeLIVERMORE, David M; MUSHTAQ, Shazad; YIGONG GE et al.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 9, pp 1972-1974, issn 0305-7453, 3 p.Article

In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermentersMUSHTAQ, Shazad; WARNER, Marina; LIVERMORE, David M et al.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 11, pp 2376-2381, issn 0305-7453, 6 p.Article

Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas sppCASTANHEIRA, Mariana; JONES, Ronald N; LIVERMORE, David M et al.Diagnostic microbiology and infectious disease. 2009, Vol 63, Num 4, pp 426-433, issn 0732-8893, 8 p.Article

Infections caused by Gram-positive bacteria: a review of the global challengeWOODFORD, Neil; LIVERMORE, David M.The Journal of infection. 2009, Vol 59, issn 0163-4453, S4-S16, SUP1Article

Future directions with daptomycinLIVERMORE, David M.Journal of antimicrobial chemotherapy (Print). 2008, Vol 62, issn 0305-7453, iii41-iii49, SUP3Article